Boothbay Fund Management’s Epizyme, Inc EPZM Stock Holding History

Boothbay Fund Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-237	Closed	-$421K	–	943
2018 Q1	$421K	Sell	237 -374	-61%	-$6.32K	0.05%	368
2017 Q4	$766K	Hold	611	–	–	0.11%	174
2017 Q3	$1.16M	Sell	611 -20,689	-97%	-$316K	0.19%	133
2017 Q2	$322K	Buy	+21,300	New	+$322K	0.07%	384

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Boothbay Fund Management's EPZM Position: Q3 2022 in Review

Boothbay Fund Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 25,338 shares — an estimated $37K sold.

Boothbay Fund Management first reported a position in EPZM in Q2 2017 and held it in 7 quarters. The position peaked at $615K in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Boothbay Fund Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Boothbay Fund Management sold 25,338 Epizyme, Inc shares in Q3 2022, an estimated $37K.
Boothbay Fund Management first reported a position in Epizyme, Inc in Q2 2017 and held it in 7 quarters.
Boothbay Fund Management's Epizyme, Inc position peaked at $615K in Q4 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.